CRA was retained by a pharmaceutical and diagnostic company to determine an appropriate intercompany royalty rate to be paid between affiliate companies for certain technological contributions to a comprehensive genomic profiling kit. As part of this assignment, CRA interviewed relevant stakeholders at both affiliates and identified and reviewed financial and business records provided by both entities. CRA’s deliverables included interim and final presentations and a report describing the valuation analysis and results.
Medtronic v. Commissioner: Rebel Curd and Robin Hart interviewed by Law360 Tax Authority
Rebel Curd, Robin Hart, and two tax lawyers were interviewed for an October 14, 2022 Law360 Tax Authority article about an unspecified transfer pricing method...